Current Status of Antioxidant Therapy for Alzheimer's Disease

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of The American Geriatrics Society

• Publication date

  1998-12-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1111/j.1532-5415.1998.tb01544.xPMID 9848820
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Epidemiology of Alzheimer's disease].

  1999cited by this paper
• Investigation by Parkinson's Disease Research Group of United Kingdom into excess mortality seen with combined levodopa and selegiline treatment in patients with early, mild Parkinson's disease: further results of randomised trial and confidential inquiry

  1998cited by this paper
• Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.

  1997cited by this paper
• A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

  1997cited by this paper
• Oxidative stress hypothesis in Alzheimer's disease.

  1997cited by this paper
• Epidemiology of Alzheimer's disease.

  1997cited by this paper
• Antioxidant reactions of all-trans retinol in phospholipid bilayers: effect of oxygen partial pressure, radical fluxes, and retinol concentration.

  1997cited by this paper
• Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.

  1996cited by this paper
• The safety of antioxidant vitamins.

  1996cited by this paper
• New therapeutic approaches to Alzheimer's disease.

  1996cited by this paper
• Rationale and Design of a Multicenter Study of Selegiline and α-Tocopherol in the Treatment of Alzheimer Disease Using Novel Clinical Outcomes

  1996cited by this paper
• Safety of antioxidant vitamins.

  1996cited by this paper
• Peripheral antioxidant enzyme activities and selenium in elderly subjects and in dementia of Alzheimer's type--place of the extracellular glutathione peroxidase.

  1996cited by this paper
• Rationale and design of a multicenter study of selegiline and alpha-tocopherol in the treatment of Alzheimer disease using novel clinical outcomes. Alzheimer's Disease Cooperative Study.

  1996cited by this paper
• Serum levels of the iron binding protein p97 are elevated in Alzheimer′s disease

  1996cited by this paper
• Haemorrhagic toxicity of a large dose of alpha-, beta-, gamma- and delta-tocopherols, ubiquinone, beta-carotene, retinol acetate and L-ascorbic acid in the rat.

  1995cited by this paper
• Haemorrhagic toxicity of a large dose of α-, β-, γ- and δ-tocopherols, ubiquinone, β-carotene, retinol acetate and L-ascorbic acid in the rat

  1995cited by this paper
• Are reactive oxygen species involved in Alzheimer's disease?

  1995cited by this paper
• Free radical mechanisms in dementia of Alzheimer type and the potential for antioxidative treatment.

  1995cited by this paper
• Oxidative damage in neurodegenerative disease.

  1994cited by this paper
• Myricetin and quercetin, the flavonoid constituents of Ginkgo biloba extract, greatly reduce oxidative metabolism in both resting and Ca(2+)-loaded brain neurons.

  1994cited by this paper
• Concentrations of alpha-tocopherol and its quinone derivative in cerebrospinal fluid from patients with vascular dementia of the Binswanger type and Alzheimer type dementia.

  1994cited by this paper
• Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease

  1994cited by this paper
• Hydrogen peroxide mediates amyloid beta protein toxicity.

  1994cited by this paper
• Concentrations of α-tocopherol and its quinone derivative in cerebrospinal fluid from patients with vascular dementia of the Binswanger type and Alzheimer type dementia

  1994cited by this paper
• The efficacy of EGb 761 in patients with senile dementia of the alzheimer type, a double‐blind, placebo‐controlled study on different levels of investigation

  1994cited by this paper
• Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease.

  1993cited by this paper
• Vitamin E protects nerve cells from amyloid βprotein toxicity

  1992cited by this paper
• Evidence for changes in the Alzheimer's disease brain cortical membrane structure mediated by cholesterol.

  1992cited by this paper
• A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains

  1992cited by this paper
• The putative role of free radicals in the loss of neuronal functioning in senescence

  1992cited by this paper
• Vitamin E protects nerve cells from amyloid beta protein toxicity.

  1992cited by this paper
• Effects of ceruloplasmin on superoxide-dependent iron release from ferritin and lipid peroxidation.

  1991cited by this paper
• Protective effect of α-tocopherol on ischemic neuronal damage in the gerbil hippocampus

  1990cited by this paper
• Protective effect of alpha-tocopherol on ischemic neuronal damage in the gerbil hippocampus.

  1990cited by this paper
• Involvement of free radicals in dementia of the Alzheimer type: a hypothesis.

  1990cited by this paper
• Autopsy Samples of Alzheimer's Cortex Show Increased Peroxidation In Vitro

  1990cited by this paper
• Diminished serotonin uptake in platelets of transgenic mice with increased Cu/Zn‐superoxide dismutase activity.

  1989cited by this paper
• Oxidants and the central nervous system: some fundamental questions. Is oxidant damage relevant to Parkinson's disease, Alzheimer's disease, traumatic injury or stroke?

  1989cited by this paper
• Antioxidant and pro-oxidant actions of the plant phenolics quercetin, gossypol and myricetin. Effects on lipid peroxidation, hydroxyl radical generation and bleomycin-dependent damage to DNA.

  1989cited by this paper
• Deprenyl suppresses the oxidant stress associated with increased dopamine turnover

  1989cited by this paper
• Increased Nigral Iron Content and Alterations in Other Metal Ions Occurring in Brain in Parkinson's Disease

  1989cited by this paper
• Down's syndrome: abnormal neuromuscular junction in tongue of transgenic mice with elevated levels of human Cu/Zn-superoxide dismutase.

  1988cited by this paper
• Excitatory Amino Acid Release from Rat Hippocampal Slices as a Consequence of Free‐Radical Formation

  1988cited by this paper
• Action of lead(II) and aluminium (III) ions on iron-stimulated lipid peroxidation in liposomes, erythrocytes and rat liver microsomal fractions.

  1988cited by this paper
• Inactivation of mammalian brain glutamine synthetase by oxygen radicals.

  1988cited by this paper
• Hippocampal membrane alteration in Alzheimer's disease.

  1986cited by this paper
• Multiple biochemical deficits in both gray and white matter of Alzheimer brains.

  1986cited by this paper
• Oxygen radicals and the nervous system

  1985cited by this paper
• Cellular toxicity and lipid peroxidation in response to mercury.

  1982cited by this paper
• Progressive Neuropathologic Lesions in Vitamin E-Deficient Rhesus Monkeys

  1981cited by this paper
• Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro.

  1978cited by this paper
• The biology of oxygen radicals.

  1978cited by this paper

• Green synthesis and evaluation of antipathogenic, antioxidant, and anticholinesterase activities of gold nanoparticles (Au NPs) from Allium cepa L. peel aqueous extract

  2023cites this paper
• Structural and Functional Changes in Cerebral Aging

  2023cites this paper
• Metabolic correlates of late midlife cognitive outcomes: findings from the 1946 British Birth Cohort

  2021cites this paper
• Cannabidiol Inhibits Tau Aggregation In Vitro

  2021cites this paper
• Esculetin as a Bifunctional Antioxidant Prevents and Counteracts the Oxidative Stress and Neuronal Death Induced by Amyloid Protein in SH-SY5Y Cells

  2020cites this paper
• Metabolic correlates of late midlife cognitive function: findings from the 1946 British Birth Cohort

  2020cites this paper
• Organismal Aging and Oxidants beyond Macromolecules Damage

  2019cites this paper
• Histopathological, immunohistochemical, and stereological analysis of the effect of Ginkgo biloba (Egb761) on the hippocampus of rats exposed to long-term cellphone radiation.

  2018cites this paper
• Inhibitory effect of the leaves and stems of Actinidia arguta on Aβ (25-35)-induced neuronal cell death and memory impairment

  2018cites this paper
• Redox theory of aging: implications for health and disease

  2017cites this paper
• A Novel Peptide from Soybean Protein Isolate Significantly Enhances Resistance of the Organism under Oxidative Stress

  2016cites this paper
• 발효 김치로부터 분리한 Lactobacillus sp. Strain KYH를 이용한 진생베리 추출물 최적 발효 공정 확립 및 생성물의 특성 분석

  2016cites this paper
• Are Polyphenols Strong Dietary Agents Against Neurotoxicity and Neurodegeneration?

  2016cites this paper
• Vitamin E: Curse or benefit in Alzheimer's disease? A systematic investigation of the impact of α-, γ- and δ-tocopherol on Aβ generation and degradation in neuroblastoma cells

  2015cites this paper
• Factors de risc en la malaltia d’Alzheimer: Estudis en animals triple transgènics 3xTg-AD

  2014cites this paper
• Review - Part of the Special Issue: Alzheimer's Disease - Amyloid, Tau and Beyond Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers

  2014cites this paper
• Cytoprotective Effects and Gene Expression Patterns Observed Based on the Antioxidant Activity of Lonicera japonica Extract

  2013cites this paper
• Cytoprotective Effects and Gene Expression Patterns Observed Based on the Antioxidant Activity of Lonicera japonica Extract

  2013cites this paper
• Oxidative modification of lipoic acid by HNE in Alzheimer disease brain

  2013cites this paper
• Antioxidative and Antimutagenic Effects and Hyperplasia Inhibitory Activity of Cancer Cells from Luffa cylindrica Extracts

  2012cites this paper
• Actinidia arguta Protects Cultured Cerebral Cortical Neurons against Glutamate-Induced Neurotoxicity via Inhibition of [Ca2+]i Increase and ROS Generation

  2012cites this paper
• Epidemiology of Alzheimer disease.

  2012cites this paper
• Epidemiology of Alzheimer disease

  2011cites this paper
• The Relations Between the Vitamins and Alzheimer Dementia

  2011cites this paper
• Activity of superoxide dysmutase, catalase and glutathione peroxidase in rats exposed to chlorpyrifos and erofloxacin.

  2011cites this paper
• Antibacterial Activities of Ginkgo biloba L. Leaf Extracts

  2011cites this paper
• Antioxidant properties of polyphenol-rich cocoa products industrially processed

  2010cites this paper
• Melatonin, Oxidative Stress, and the Aging Brain

  2010cites this paper
• Consumo de frutas e hortaliças e funcionamento cognitivo em idosos

  2010cites this paper
• Functional Activities of Ethanol Extracts from Flammulina velutipes

  2010cites this paper
• Nanoparticle and iron chelators as a potential novel Alzheimer therapy.

  2010cites this paper
• Antioxidant properties of tea and herbal infusions - a short report.

  2010cites this paper
• Effects of Rosmarinus officinalis extract on induced nitric oxide and stimulated proinxammatory mediators via-bacterial lipopolysaccharide (LPS).

  2009cites this paper
• Aralia cordata protects against amyloid beta protein (25-35)-induced neurotoxicity in cultured neurons and has antidementia activities in mice.

  2009cites this paper
• Chronic antioxidant therapy reduces oxidative stress in a mouse model of Alzheimer's disease

  2009cites this paper
• Ethanol Extract of Three Plants of Curcuma longae Radix, Phellinus linteus, and Scutellariae Radix Inhibits Amyloid $\beta$ Protein (25-35)-Induced Neurotoxicity in Cultured Neurons and Memory Impairment in Mice

  2009cites this paper
• Alzheimer’s Disease and Other Neurodegenerative Disorders

  2009cites this paper
• Investigation of the mechanism of enhanced effect of EGCG on huperzine A's inhibition of acetylcholinesterase activity in rats by a multispectroscopic method.

  2008cites this paper
• Effects of Adenophora triphylla Ethylacetate Extract on mRNA Levels of Antioxidant Enzymes in Human HepG2 Cells

  2008cites this paper
• Cellular and Biochemical Actions of Melatonin which Protect Against Free Radicals: Role in Neurodegenerative Disorders

  2008cites this paper
• Oxidative stress related changes in the brain of hypercholesterolemic rabbits

  2008cites this paper
• Moutan Cortex Extract Inhibits Amyloid ${\beta}$ Protein (25-35)-induced Neurotoxicity in Cultured Rat Cortical Neurons

  2008cites this paper
• Antioxidant therapy in Alzheimer's disease: theory and practice.

  2008cites this paper
• Prevention and treatment of Alzheimer disease and aging: antioxidants.

  2007cites this paper
• Hallmarks of protein oxidative damage in neurodegenerative diseases: focus on Alzheimer’s disease

  2007cites this paper
• Melatonin and the aging brain.

  2007cites this paper
• Use of herbal preparations in the treatment of oxidant-mediated inflammatory disorders.

  2007cites this paper
• Cellular Therapy Using Microglial Cells

  2007cites this paper
• Improved production by fed-batch cultivation and some properties of Cu/Zn-superoxide dismutase from the fungal strain Humicola lutea 103

  2007cites this paper
• Diet and Alzheimer’s disease

  2007cites this paper
• Protective effects of Glycyrrhiza uralensis Fisch. on the cognitive deficits caused by β-amyloid peptide 25–35 in young mice

  2006cites this paper
• Nutritional factors, cognitive decline, and dementia.

  2006cites this paper
• Effect of vitamin E on memory retention in rats: possible involvement of cholinergic system.

  2006cites this paper
• Tocopherol-mediated modulation of age-related changes in microglial cells: turnover of extracellular oxidized protein material.

  2006cites this paper
• Nutrition and Brain Nutrition and Brain Nestlé Nutrition Workshop Series Clinical & Performance Program Volume 5

  2005cites this paper
• Evaluation of hepatoprotective potential of HESA-A (a marine compound) pretreatment against thioacetamide-induced hepatic damage in rabbits.

  2005cites this paper
• Nanoparticle and other metal chelation therapeutics in Alzheimer disease.

  2005cites this paper
• Ginkgo biloba Extract EGb 761 Extends Life Span and Attenuates H2O2 Levels in a Caenorhabditis elegans Model of Alzheimer’s Disease

  2005cites this paper
• Retardation of Brain Aging by Chronic Treatment with Melatonin

  2004cites this paper
• An overview of the pathophysiology of neurodegenerative disorders.

  2004cites this paper
• Alzheimer's disease: neuropathologic findings and recent advances in imaging.

  2004cites this paper
• Modulation of Hippocampal Plasticity and Cognitive Behavior by Short-term Blueberry Supplementation in Aged Rats

  2004cites this paper
• Metals in our minds: therapeutic implications for neurodegenerative disorders.

  2004cites this paper
• Alcohol Intake and Risk of Dementia

  2004cites this paper
• Dietary factors and Alzheimer's disease.

  2004cites this paper
• Ginkgo biloba prevents mobile phone-induced oxidative stress in rat brain.

  2004cites this paper
• N-Acetyl-L-Cystein downregulates β-amyloid precursor protein gene transcription in human neuroblastoma cells

  2004cites this paper
• Tocopherol (Vitamin E) in Alzheimer’s Disease and Other Neurodegenerative Disorders

  2004cites this paper
• Delirium and Dementia

  2004cites this paper
• Elevation of oxidative free radicals in Alzheimer's disease models can be attenuated by Ginkgo biloba extract EGb 761

  2003cites this paper
• Activation of microglia: A neuroinflammatory role for CAP37

  2003cites this paper
• Ginkgo and memory.

  2003cites this paper
• Antioxidant Properties of Galantamine Hydrobromide

  2003cites this paper
• Is antioxidant use protective of cognitive function in the community-dwelling elderly?

  2003cites this paper
• Antioxidant Properties of Galantamine Hydrobromide

  2003cites this paper
• Antioxidant treatment in alzheimer’s disease

  2003cites this paper
• Antioxidant strategies in protection against neurodegenerative disorders

  2003cites this paper
• Antioxidant vitamin intake and risk of Alzheimer disease.

  2003influential citation
• Antioxidant capacity in Ginkgo biloba

  2002cites this paper
• Antioxidants and Alzheimer's disease: from bench to bedside (and back again)

  2002cites this paper
• Qualitative versus quantitative caloric intake: are they equivalent paths to successful aging?

  2002cites this paper
• Caloric intake and the risk of Alzheimer disease.

  2002cites this paper
• Cognitive and Motor Symptoms in Dementia: Focus on Dementia with Lewy Bodies

  2002cites this paper
• Neuroplasticity in Alzheimer's disease

  2002cites this paper
• Prodrug and covalent linker strategies for the solubilization of dual-action antioxidants/iron chelators.

  2002cites this paper
• Roles of vitamins E and C on neurodegenerative diseases and cognitive performance.

  2002cites this paper
• [Monoamine oxidase inhibitors: prospects for the use in clinical practice].

  2002cites this paper
• Event related evoked potentials in dementia: role of vitamin E.

  2002cites this paper
• Alzheimeri tõve etiopatogeneesi mitmetahuline mehhanism ja ravi võimalikud strateegiad

  2002cites this paper
• Caloric Restriction Versus a Diet High in Antioxidants: Are they Equipotent in Altering or Reversing the Course of Aging?

  2002cites this paper
• Effects of Ginkgo biloba extract (EGb 761) and quercetin on lipopolysaccharide-induced release of nitric oxide.

  2001cites this paper
• Diet-related prevention of Alzheimer's disease: different hypotheses.

  2001cites this paper
• A possible emerging role of phytochemicals in improving age-related neurological dysfunctions: a multiplicity of effects.

  2001cites this paper
• The Encyclopedia of Aging

  2001cites this paper
• Oxygen Free Radicals and Arterial Hypertension

  2001cites this paper
• Nutrition and cognitive impairment in the elderly

  2001cites this paper
• Nutritional Management of Individuals with Alzheimer's Disease and Other Progressive Dementias

  2001cites this paper
• Nutrition and Cognitive Function

  2001cites this paper
• [Experimental therapeutic models for fragile X syndrome].

  2001cites this paper
• N-Acetyl-L-Cystein downregulates beta-amyloid precursor protein gene transcription in human neuroblastoma cells.

  2001cites this paper